Sandra Scherbeijn

1.0k total citations · 1 hit paper
11 papers, 371 citations indexed

About

Sandra Scherbeijn is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Sandra Scherbeijn has authored 11 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 4 papers in Epidemiology and 3 papers in Virology. Recurrent topics in Sandra Scherbeijn's work include SARS-CoV-2 and COVID-19 Research (2 papers), HIV Research and Treatment (2 papers) and Hepatitis Viruses Studies and Epidemiology (2 papers). Sandra Scherbeijn is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (2 papers), HIV Research and Treatment (2 papers) and Hepatitis Viruses Studies and Epidemiology (2 papers). Sandra Scherbeijn collaborates with scholars based in Netherlands, Germany and Slovenia. Sandra Scherbeijn's co-authors include Harry L.A. Janssen, Bettina E. Hansen, Jurriën G.P. Reijnders, Charles A. Boucher, Milan J. Sonneveld, Vincent Rijckborst, Corine H. GeurtsvanKessel, Hannelore M Götz, Marion Koopmans and Eric C. M. Van Gorp and has published in prestigious journals such as Nature Medicine, Journal of Hepatology and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

Sandra Scherbeijn

9 papers receiving 366 citations

Hit Papers

Low levels of monkeypox virus-neutralizing antibodies aft... 2022 2026 2023 2024 2022 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra Scherbeijn Netherlands 6 234 156 122 116 68 11 371
Markus von Schaewen United States 10 178 0.8× 40 0.3× 52 0.4× 199 1.7× 51 0.8× 13 299
Abraham J. Kandathil United States 11 152 0.6× 237 1.5× 49 0.4× 118 1.0× 194 2.9× 26 427
Pantxika Bellecave France 12 225 1.0× 206 1.3× 154 1.3× 222 1.9× 224 3.3× 31 575
Elisabeth Daghofer Austria 10 168 0.7× 36 0.2× 60 0.5× 97 0.8× 134 2.0× 15 314
Alexandra Oteiza France 7 135 0.6× 52 0.3× 150 1.2× 19 0.2× 108 1.6× 7 426
Natasha Persaud United States 4 152 0.6× 149 1.0× 79 0.6× 13 0.1× 60 0.9× 5 366
Mark B. Stoddard United States 10 304 1.3× 78 0.5× 118 1.0× 231 2.0× 106 1.6× 10 518
Michelle Ainouze France 10 252 1.1× 34 0.2× 61 0.5× 49 0.4× 86 1.3× 11 348
Daniëlla Mortier Netherlands 11 212 0.9× 122 0.8× 74 0.6× 82 0.7× 110 1.6× 21 420
Marie-Lise Blondot France 8 245 1.0× 85 0.5× 94 0.8× 75 0.6× 139 2.0× 14 361

Countries citing papers authored by Sandra Scherbeijn

Since Specialization
Citations

This map shows the geographic impact of Sandra Scherbeijn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Scherbeijn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Scherbeijn more than expected).

Fields of papers citing papers by Sandra Scherbeijn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Scherbeijn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Scherbeijn. The network helps show where Sandra Scherbeijn may publish in the future.

Co-authorship network of co-authors of Sandra Scherbeijn

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Scherbeijn. A scholar is included among the top collaborators of Sandra Scherbeijn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Scherbeijn. Sandra Scherbeijn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Scherbeijn, Sandra, et al.. (2025). Strong association with remote EBV infection in children with MS as opposed to other acquired demyelinating disorders. Journal of Neurology Neurosurgery & Psychiatry. 96(10). 975–980.
2.
Hoek, Rogier A.S., Siqi Liu, Corine H. GeurtsvanKessel, et al.. (2024). Humoral and cellular immune responses after COVID-19 vaccination of lung transplant recipients and patients on the waiting list: a 6-month follow-up. Frontiers in Immunology. 14. 1254659–1254659.
3.
Hoek, Rogier A.S., Erik A.M. Verschuuren, Rory D. de Vries, et al.. (2022). High torque tenovirus (TTV) load before first vaccine dose is associated with poor serological response to COVID-19 vaccination in lung transplant recipients. The Journal of Heart and Lung Transplantation. 41(6). 765–772. 20 indexed citations
4.
Zaeck, Luca M., Mart M. Lamers, Babs E. Verstrepen, et al.. (2022). Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals. Nature Medicine. 29(1). 270–278. 147 indexed citations breakdown →
5.
Comvalius, Anouskha D., Corine H. GeurtsvanKessel, Lennert Slobbe, et al.. (2021). Measles seroprevalence among Dutch travelling families. Travel Medicine and Infectious Disease. 44. 102194–102194. 4 indexed citations
6.
Reusken, Chantal, Sandra Scherbeijn, Felicity Chandler, et al.. (2019). An evaluation of serological methods to diagnose tick-borne encephalitis from serum and cerebrospinal fluid. Journal of Clinical Virology. 120. 78–83. 29 indexed citations
7.
GeurtsvanKessel, Corine H., Lennert Slobbe, Sandra Scherbeijn, et al.. (2019). Adherence to hepatitis A travel health guidelines: A cross-sectional seroprevalence study in Dutch travelling families - The Dutch travel Vaccination Study (DiVeST). Travel Medicine and Infectious Disease. 32. 101511–101511. 4 indexed citations
8.
Tienen, Carla van, et al.. (2017). The performance of the Alere HIV combo point-of-care test on stored serum samples; useful for detection of early HIV-1 infections?. Sexually Transmitted Infections. 94(5). 331–333. 17 indexed citations
9.
Kreft, Karim L., Gijsbert P. van Nierop, Sandra Scherbeijn, et al.. (2017). Elevated EBNA-1 IgG in MS is associated with genetic MS risk variants. Neurology Neuroimmunology & Neuroinflammation. 4(6). e406–e406. 28 indexed citations
10.
Tienen, Carla van, et al.. (2016). The Alere HIV Combo point-of-care test; Useful in clinical practice?. Journal of Clinical Virology. 82. S94–S94. 1 indexed citations
11.
Reijnders, Jurriën G.P., Vincent Rijckborst, Milan J. Sonneveld, et al.. (2010). Kinetics of hepatitis B surface antigen differ between treatment with peginterferon and entecavir. Journal of Hepatology. 54(3). 449–454. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026